353 related articles for article (PubMed ID: 26722864)
21. Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant.
Shiba E; Matsuyama A; Shibuya R; Yabuki K; Harada H; Nakamoto M; Kasai T; Hisaoka M
Diagn Pathol; 2016 Mar; 11():26. PubMed ID: 26956379
[TBL] [Abstract][Full Text] [Related]
22. A cytogenetic analysis of 2 cases of phosphaturic mesenchymal tumor of mixed connective tissue type.
Graham RP; Hodge JC; Folpe AL; Oliveira AM; Meyer KJ; Jenkins RB; Sim FH; Sukov WR
Hum Pathol; 2012 Aug; 43(8):1334-8. PubMed ID: 22503486
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
[TBL] [Abstract][Full Text] [Related]
24. Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the "nonphosphaturic" variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization.
Sent-Doux KN; Mackinnon C; Lee JC; Folpe AL; Habeeb O
Hum Pathol; 2018 Oct; 80():94-98. PubMed ID: 29514106
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic osteomalacia associated with a meningeal phosphaturic mesenchymal tumor. Case report.
David K; Revesz T; Kratimenos G; Krausz T; Crockard HA
J Neurosurg; 1996 Feb; 84(2):288-92. PubMed ID: 8592237
[TBL] [Abstract][Full Text] [Related]
26. Phosphaturic mesenchymal tumor of the nasal cavity and paranasal sinuses: A clinical curiosity presenting a diagnostic challenge.
Kane SV; Kakkar A; Oza N; Sridhar E; Pai PS
Auris Nasus Larynx; 2018 Apr; 45(2):377-383. PubMed ID: 28579442
[TBL] [Abstract][Full Text] [Related]
27. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
[TBL] [Abstract][Full Text] [Related]
28. Recurrent phosphaturic mesenchymal tumour of the temporal bone causing deafness and facial nerve palsy.
Syed MI; Chatzimichalis M; Rössle M; Huber AM
J Laryngol Otol; 2012 Jul; 126(7):721-4. PubMed ID: 22642807
[TBL] [Abstract][Full Text] [Related]
29. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
[TBL] [Abstract][Full Text] [Related]
30. Phosphaturic mesenchymal tumor: A chondromyxoid fibroma-like type.
Koga K; Iwasaki H; Nabeshima K
J Dermatol; 2023 Nov; 50(11):1484-1487. PubMed ID: 37350024
[TBL] [Abstract][Full Text] [Related]
31. Pathologic quiz case. A 36-year-old woman with muscle pain and weakness. Phosphaturic mesenchymal tumor (mixed connective tissue variant)/oncogenic osteomalacia.
Reis-Filho JS; Paiva ME; Lopes JM
Arch Pathol Lab Med; 2002 Oct; 126(10):1245-6. PubMed ID: 12385334
[No Abstract] [Full Text] [Related]
32. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.
Folpe AL; Fanburg-Smith JC; Billings SD; Bisceglia M; Bertoni F; Cho JY; Econs MJ; Inwards CY; Jan de Beur SM; Mentzel T; Montgomery E; Michal M; Miettinen M; Mills SE; Reith JD; O'Connell JX; Rosenberg AE; Rubin BP; Sweet DE; Vinh TN; Wold LE; Wehrli BM; White KE; Zaino RJ; Weiss SW
Am J Surg Pathol; 2004 Jan; 28(1):1-30. PubMed ID: 14707860
[TBL] [Abstract][Full Text] [Related]
33. A phosphaturic mesenchymal tumor of the floor of the mouth with oncogenic osteomalacia: report of a case.
Yun KI; Kim DH; Pyo SW
J Oral Maxillofac Surg; 2009 Feb; 67(2):402-5. PubMed ID: 19138617
[No Abstract] [Full Text] [Related]
34. Phosphaturic mesenchymal tumor: a report of 6 patients treated at a single institution and comparison with reported series.
Fatani HA; Sunbuli M; Lai SY; Bell D
Ann Diagn Pathol; 2013 Aug; 17(4):319-21. PubMed ID: 22981782
[TBL] [Abstract][Full Text] [Related]
35. A case of phosphaturic mesenchymal tumor.
Pallavi R; Ravella PM; Gupta P; Popescu A
Am J Ther; 2015; 22(2):e57-61. PubMed ID: 24247100
[TBL] [Abstract][Full Text] [Related]
36. Osteomalacia caused by skull base tumors: report of 2 cases.
Uno T; Kawai K; Kunii N; Fukumoto S; Shibahara J; Motoi T; Saito N
Neurosurgery; 2011 Jul; 69(1):E239-44; discussion E244. PubMed ID: 21796068
[TBL] [Abstract][Full Text] [Related]
37. Phosphaturic mesenchymal tumor-induced rickets.
Reyes-Múgica M; Arnsmeier SL; Backeljauw PF; Persing J; Ellis B; Carpenter TO
Pediatr Dev Pathol; 2000; 3(1):61-9. PubMed ID: 10594133
[TBL] [Abstract][Full Text] [Related]
38. Tumor-induced osteomalacia caused by a massive phosphaturic mesenchymal tumor of the acetabulum: A case report.
Nakamura K; Ohishi M; Matsunobu T; Nakashima Y; Sakamoto A; Maekawa A; Oda Y; Iwamoto Y
Mod Rheumatol; 2018 Sep; 28(5):906-910. PubMed ID: 27141918
[TBL] [Abstract][Full Text] [Related]
39. Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue.
Uramoto N; Furukawa M; Yoshizaki T
Auris Nasus Larynx; 2009 Feb; 36(1):104-5. PubMed ID: 18329207
[TBL] [Abstract][Full Text] [Related]
40. Successful CT guided cryoablation of phosphaturic mesenchymal tumor in the soft tissues causing tumor-induced osteomalacia: a case report.
Cowan S; Lozano-Calderon SA; Uppot RN; Sajed D; Huang AJ
Skeletal Radiol; 2017 Feb; 46(2):273-277. PubMed ID: 27921126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
